Complement factors and their receptors
Immunopharmacology, ISSN: 0162-3109, Vol: 38, Issue: 1, Page: 3-15
1997
- 139Citations
- 41Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations139
- Citation Indexes139
- 139
- CrossRef122
- Captures41
- Readers41
- 41
Review Description
In summary, recent advances in molecular cloning of anaphylatoxins and the anaphylatoxin receptors add new dimensions to our investigations and understanding of the molecular mechanisms involved in anaphylatoxin action. Combining knowledge accumulated from peptide modeling of the ligands with mutagenesis studies of these ligands and their receptors makes it possible to more accurately model interactive sites and understand the sequence of molecular interactions required for cellular activation. In addition, these new developments provide valuable tools for investigating, yet unknown, activities and cellular targets of the anaphylatoxin molecules.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S016231099700088X; http://dx.doi.org/10.1016/s0162-3109(97)00088-x; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0031474771&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/9476110; https://linkinghub.elsevier.com/retrieve/pii/S016231099700088X; http://linkinghub.elsevier.com/retrieve/pii/S016231099700088X; http://api.elsevier.com/content/article/PII:S016231099700088X?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S016231099700088X?httpAccept=text/plain; http://dx.doi.org/10.1016/s0162-3109%2897%2900088-x; https://dx.doi.org/10.1016/s0162-3109%2897%2900088-x
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know